Cancer wars: Natural products strike back
Natural products have historically been a mainstay source of anticancer drugs, but in the 90’s they fell out of favor in pharmaceutical companies with the emergence of targeted therapies, which rely on antibodies or small synthetic molecules identified by high throughput screening. Although targeted...
Main Authors: | Christine eBasmadjian, Qian eZhao, Amel eDjehal, Embarek eBentouhami, Canan G Nebigil, Roger A Johnson, Maria eSerova, Armand eDe Gramont, Sandrine eFaivre, Eric eRaymond, Laurent G. Désaubry |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-05-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fchem.2014.00020/full |
Similar Items
-
Updates in Anthracycline-Mediated Cardiotoxicity
by: Canan G. Nebigil, et al.
Published: (2018-11-01) -
Discovery of A class GPCR ligands for probing signal transduction pathways
by: Simone eBrogi, et al.
Published: (2014-11-01) -
Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments
by: Anais Audebrand, et al.
Published: (2020-01-01) -
Studies on the Effects of Plant and Food Constituents on Cyclooxygenase-2 : Aspects in Inflammation and Cancer
by: Huss, Ulrika
Published: (2003) -
Bioassay Development for Identification of Cyclooxygenase-2 Inhibitors of Natural Origin
by: Ringbom, Therese
Published: (2002)